Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma

19 Mar 2021

Abstract excerpt

Advances over the last two decades have resulted in a significant improvement in survival of patients with multiple myeloma (MM)—primarily driven by the emergence of immunomodulators (IMiDs), proteasome inhibitors (PI) and monoclonal antibodies. Despite these improvements, high-dose melphalan (HDM)-based autologous stem cell transplantation (SCT) followed by lenalidomide maintenance remains part of standard...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Multiple Myeloma Research and Treatments
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33741897
DOI: 10.1038/s41408-021-00454-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myelomaPMID 33741897Read ↗

The role of high‐dose melphalan with autologous stem‐cell transplant in multiple myeloma: is it time for a paradigm shift?Semantic proximity Read ↗

Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myelomaSemantic proximity Read ↗

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantationSemantic proximity Read ↗

Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.Semantic proximity Read ↗

High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes.Semantic proximity Read ↗

Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India – Knowing the UnknownSemantic proximity Read ↗

Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or olderSemantic proximity Read ↗

Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple MyelomaSemantic proximity Read ↗

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group databaseSemantic proximity Read ↗

Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSemantic proximity Read ↗

Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationSemantic proximity Read ↗

Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.